PF-Atlas › Clinical Trials › NCT04657978

Substrate Guided Ablation Therapy for Atrial Fibrillation

Substrate guided left atrial ablation · Not specified

Registry ID
NCT04657978
Phase
Not specified
Status
Unknown
Drug / intervention
Substrate guided left atrial ablation
Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Start
2021-01

About this trial

Substrate guided left atrial ablation is evaluated in NCT04657978, a idiopathic pulmonary fibrosis study sponsored by Royal Brompton & Harefield NHS Foundation Trust. Current status: Unknown.

View NCT04657978 on ClinicalTrials.gov →

Explore related

All Substrate guided left atrial ablation trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT04657978 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.